Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Recombinant Influenza Vaccine in Adult Allogeneic HSCT Recipients
NCT00766285Phase 2Withdrawn
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Sep 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine (recombinant) in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Status: withdrawn.
02
Drugs
influenza vaccine (recombinant)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00766285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766285.